Independent directory Public ClinicalTrials.gov records United States
Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 4, 2026, 5:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–8 of 8 matching trials from the live ClinicalTrials.gov search.
Completed Not applicable Interventional

Janus Feasibility Study

NCT03985527
Conditions
Sleep Apnea Syndromes
Interventions
Transvenous nerve stimulation
Device
Lead sponsor
Respicardia, Inc.
Industry
Eligibility
18 Years and older
Enrollment
29 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2025
U.S. locations
3
States / cities
Winston-Salem, North Carolina • Columbus, Ohio • Bryn Mawr, Pennsylvania
Conditions
Heart Failure
Interventions
Not listed
Lead sponsor
Respicardia, Inc.
Industry
Eligibility
18 Years to 85 Years
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2010
U.S. locations
6
States / cities
Birmingham, Alabama • Baltimore, Maryland • Cincinnati, Ohio + 3 more
Active, not recruiting No phase listed Observational

remedē System Therapy Study

NCT03884660
Conditions
Central Sleep Apnea
Interventions
remede System
Device
Lead sponsor
Respicardia, Inc.
Industry
Eligibility
18 Years and older
Enrollment
225 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2030
U.S. locations
29
States / cities
Phoenix, Arizona • Scottsdale, Arizona • San Francisco, California + 24 more
Conditions
Central Sleep Apnea, Heart Failure
Interventions
Not listed
Lead sponsor
Respicardia, Inc.
Industry
Eligibility
18 Years and older
Enrollment
5 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2012
U.S. locations
3
States / cities
Minneapolis, Minnesota • Saint Cloud, Minnesota • San Antonio, Texas
Completed Phase 2 Interventional Results available

Chronic Evaluation of Respicardia Therapy

NCT01124370
Conditions
Sleep Disordered Breathing, Cheyne Stokes Respiration, Periodic Breathing, Sleep Apnea, Central Sleep Apnea
Interventions
remedē (TM) system
Device
Lead sponsor
Respicardia, Inc.
Industry
Eligibility
18 Years and older
Enrollment
57 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010 – 2014
U.S. locations
5
States / cities
Lincoln, Nebraska • Columbus, Ohio • Lancaster, Pennsylvania + 2 more
Completed Not applicable Interventional Results available

Respicardia, Inc. Pivotal Trial of the remedē System

NCT01816776
Conditions
Sleep Apnea, Central, Sleep Disordered Breathing, Heart Failure
Interventions
Treatment Group (transvenous stimulation of the phrenic nerve), Control Group (Optimal Medical Therapy)
Device
Lead sponsor
Respicardia, Inc.
Industry
Eligibility
18 Years and older
Enrollment
151 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2017
U.S. locations
23
States / cities
Los Angeles, California • Jacksonville, Florida • Downers Grove, Illinois + 19 more
Completed No phase listed Observational Results available

Post Approval Study of the remedē System

NCT03425188
Conditions
Central Sleep Apnea
Interventions
Not listed
Lead sponsor
Respicardia, Inc.
Industry
Eligibility
21 Years and older
Enrollment
53 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2020
U.S. locations
16
States / cities
Los Angeles, California • Jacksonville, Florida • Downers Grove, Illinois + 13 more
Conditions
Sleep Disordered Breathing, Cheyne-Stokes Respiration, Sleep Apnea
Interventions
Phrenic stimulation device
Device
Lead sponsor
Respicardia, Inc.
Industry
Eligibility
18 Years and older
Enrollment
50 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2013
U.S. locations
3
States / cities
Minneapolis, Minnesota • Cincinnati, Ohio • Columbus, Ohio